We are driven by collaboration, innovation, and a shared commitment to advancing knowledge and improving the lives of mothers and infants in Africa and beyond
With diverse backgrounds and roles, including postdoctoral researchers, PhD candidates, laboratory technologists, coordinators, and administrators, the RIRCA group boasts a dynamic, cutting-edge approach.
RIRCA is a response to the pressing need in Africa for innovative solutions that use immunology research to enhance maternal and child health, offering newborns a brighter and healthier start in life.
RECENT PUBLICATIONS
Gachogo R, Happel AU, Alinde B, Gray CM, Jaspan H, Dzanibe S. Reduced anti-viral IgG repertoire in HIV-exposed but uninfected infants compared to HIV-unexposed infants. iScience. 2024 Jun 15;27(7):110282. doi: 10.1016/j.isci.2024.110282. PMID: 39040054; PMCID: PMC11261148.
Dzanibe S, Wilk AJ, Canny S, Ranganath T, Alinde B, Rubelt F, Huang H, Davis MM, Holmes SP, Jaspan HB, Blish CA, Gray CM. Premature skewing of T cell receptor clonality and delayed memory expansion in HIV-exposed infants. Nat Commun. 2024 May 14;15(1):4080. doi: 10.1038/s41467-024-47955-5. PubMed PMID: 38744812; PubMed Central PMCID: PMC11093981.
Madlala HP, Myer L, Geffen H, Rusch J, Shey MS, Meyer D, Goedecke JH, Malaba TR, Gray CM, Newell ML, Jao J. Inflammatory markers in pregnancy are associated with postpartum weight in South African women living with HIV on antiretroviral therapy. J Acquir Immune Defic Syndr. 2024 Mar 4;. doi: 10.1097/QAI.0000000000003406. [Epub ahead of print] PubMed PMID: 38465914.